When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
HRTX - Heron's CRL Is Just A Minor Bump And Resubmission For Approval Will Come Quickly
Heron Therapeutics Inc.
Heron Therapeutics (HRTX) announced that the FDA had given a complete response letter ((CRL)) for HTX-011 for the treatment of patients with postoperative pain. I believe that this is a temporary delay for approval, because the issue noted in the CRL is an easy matter to resolve. The biotech also already has FDA approved drugs, so the selloff is quite unjustified based on this fact alone. Heron should be able to meet with the FDA and set certain guidelines to resolve this issue in the coming year.